REGENCIN Trademark

Trademark Overview


On Wednesday, August 27, 2008, a trademark application was filed for REGENCIN with the United States Patent and Trademark Office. The USPTO has given the REGENCIN trademark a serial number of 77556562. The federal status of this trademark filing is ABANDONED - EXPRESS as of Wednesday, September 17, 2008. This trademark is owned by Pfizer Inc.. The REGENCIN trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business consulting and information services relating to regenerative medicine, biotechnology, and genetics
regencin

General Information


Serial Number77556562
Word MarkREGENCIN
Filing DateWednesday, August 27, 2008
Status601 - ABANDONED - EXPRESS
Status DateWednesday, September 17, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBusiness consulting and information services relating to regenerative medicine, biotechnology, and genetics

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, September 2, 2008
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Wednesday, September 17, 2008ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Wednesday, September 17, 2008ABANDONMENT - EXPRESS MAILED
Tuesday, September 16, 2008TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, September 2, 2008NEW APPLICATION ENTERED IN TRAM